Beijing genotype of Mycobacterium tuberculosis is significantly associated with linezolid resistance in multidrug-resistant and extensively drug-resistant tuberculosis in China

International Journal of Antimicrobial Agents

Volumn 43, Issue 3, 2014, Pages 231-235

  Zhang, Zhijian ^a   Pang, Yu ^a,b   Wang, Yufeng ^b   Liu, Changting ^a   Zhao, Yanlin ^b  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

Linezolid; Multidrug resistance; Tuberculosis

Indexed keywords

ASPARTIC ACID; ETHAMBUTOL; HISTIDINE; ISONIAZID; KANAMYCIN; LINEZOLID; OFLOXACIN; RIFAMPICIN; RNA 23S; STREPTOMYCIN;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; CHINA; CONTROLLED STUDY; DRUG EFFICACY; EXTENSIVELY DRUG RESISTANT TUBERCULOSIS; GENE MUTATION; GENE SEQUENCE; GENOTYPE; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; RPLC GENE; RPLD GENE;

LINEZOLID; MULTIDRUG RESISTANCE; TUBERCULOSIS;

ACETAMIDES; ANTITUBERCULAR AGENTS; CHINA; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENOTYPE; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; MUTATION; MYCOBACTERIUM TUBERCULOSIS; OXAZOLIDINONES; PREVALENCE; RNA, RIBOSOMAL, 23S; SEQUENCE ANALYSIS, DNA; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84896488180     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2013.12.007     Document Type: Article

References (30)

1. World Health Organization Global tuberculosis report 2012 2012 WHO Geneva, Switzerland
2. World Health Organization Multidrug and extensively drug-resistant TB (M/XDR-TB): 2010 global report on surveillance and response 2010 WHO Geneva, Switzerland WHO/HTM/TB/2010.3
3. Y. Pang, Y. Zhou, B. Zhao, G. Liu, G. Jiang, and H. Xia et al. Spoligotyping and drug resistance analysis of Mycobacterium tuberculosis strains from national survey in China PLoS One 7 2012 e32976
4. Y. Zhao, S. Xu, L. Wang, D.P. Chin, S. Wang, and G. Jiang et al. National survey of drug-resistant tuberculosis in China N Engl J Med 366 2012 2161 2170
5. L. Wang, J. Liu, and D.P. Chin Progress in tuberculosis control and the evolving public-health system in China Lancet 369 2007 691 696
6. H.A. Anger, F. Dworkin, S. Sharma, S.S. Munsiff, D.M. Nilsen, and S.D. Ahuja Linezolid use for treatment of multidrug-resistant and extensively drug-resistant tuberculosis, New York City, 2000-06 J Antimicrob Chemother 65 2010 775 783
7. L. Alcalá, M.J. Ruiz-Serrano, C. Pérez-Fernández Turégano, D. García De Viedma, M. Díaz-Infantes, and M. Marín-Arriaza et al. In vitro activities of linezolid against clinical isolates of Mycobacterium tuberculosis that are susceptible or resistant to first-line antituberculous drugs Antimicrob Agents Chemother 47 2003 416 417
8. R. Dietze, D.J. Hadad, B. McGee, L.P. Molino, E.L. Maciel, and C.A. Peloquin et al. Early and extended early bactericidal activity of linezolid in pulmonary tuberculosis Am J Respir Crit Care Med 178 2008 1180 1185
9. M.H. Cynamon, S.P. Klemens, C.A. Sharpe, and S. Chase Activities of several novel oxazolidinones against Mycobacterium tuberculosis in a murine model Antimicrob Agents Chemother 43 1999 1189 1191
10. G.F. Schecter, C. Scott, L. True, A. Raftery, J. Flood, and S. Mase Linezolid in the treatment of multidrug-resistant tuberculosis Clin Infect Dis 50 2010 49 55
11. M. Lee, J. Lee, M.W. Carroll, H. Choi, S. Min, and T. Song et al. Linezolid for treatment of chronic extensively drug-resistant tuberculosis N Engl J Med 367 2012 1508 1518
12. B. Bozdogan, and P.C. Appelbaum Oxazolidinones: activity, mode of action, and mechanism of resistance Int J Antimicrob Agents 23 2004 113 119
13. K.S. Long, and B. Vester Resistance to linezolid caused by modifications at its binding site on the ribosome Antimicrob Agents Chemother 56 2012 603 612
14. P. Beckert, D. Hillemann, T.A. Kohl, J. Kalinowski, E. Richter, and S. Niemann et al. rplC T460C identified as a dominant mutation in linezolid-resistant Mycobacterium tuberculosis strains Antimicrob Agents Chemother 56 2012 2743 2745
15. D. Hillemann, S. Rüsch-Gerdes, and E. Richter In vitro-selected linezolid-resistant Mycobacterium tuberculosis mutants Antimicrob Agents Chemother 52 2008 800 801
16. Y. Pang, Y. Zhou, S. Wang, J. Lu, B. Lu, and G. He et al. A novel method based on high resolution melting (HRM) analysis for MIRU-VNTR genotyping of Mycobacterium tuberculosis J Microbiol Methods 86 2011 291 297
17. Y. Pang, J. Lu, Y. Wang, Y. Song, S. Wang, and Y. Zhao Study of the rifampin monoresistance mechanism in Mycobacterium tuberculosis Antimicrob Agents Chemother 57 2013 893 900
18. I. Parwati, R. van Crevel, and D. van Soolingen Possible underlying mechanisms for successful emergence of the Mycobacterium tuberculosis Beijing genotype strains Lancet Infect Dis 10 2010 103 111
19. T.N. Buu, M.N. Huyen, N.T. Lan, H.T. Quy, N.V. Hen, and M. Zignol et al. The Beijing genotype is associated with young age and multidrug-resistant tuberculosis in rural Vietnam Int J Tuberc Lung Dis 13 2009 900 906
20. D.D. Anh, M.W. Borgdorff, L.N. Van, N.T. Lan, T. van Gorkom, and K. Kremer et al. Mycobacterium tuberculosis Beijing genotype emerging in Vietnam Emerg Infect Dis 6 2000 302 305
21. O.S. Toungoussova, P. Sandven, A.O. Mariandyshev, N.I. Nizovtseva, G. Bjune, and D.A. Caugant Spread of drug-resistant Mycobacterium tuberculosis strains of the Beijing genotype in the Archangel Oblast, Russia J Clin Microbiol 40 2002 1930 1937
22. W.M. Prodinger, P. Bunyaratvej, R. Prachaktam, and M. Pavlic Mycobacterium tuberculosis isolates of Beijing genotype in Thailand Emerg Infect Dis 7 2001 483 484
23. D. Hillemann, T. Kubica, S. Rusch-Gerdes, and S. Niemann Disequilibrium in distribution of resistance mutations among Mycobacterium tuberculosis Beijing and non-Beijing strains isolated from patients in Germany Antimicrob Agents Chemother 49 2005 1229 1231
24. I. Mokrousov, O. Narvskaya, T. Otten, E. Limeschenko, L. Steklova, and B. Vyshnevskiy High prevalence of KatG Ser315Thr substitution among isoniazid-resistant Mycobacterium tuberculosis clinical isolates from northwestern Russia, 1996 to 2001 Antimicrob Agents Chemother 46 2002 1417 1424
25. D.A. Duong, T.H. Nguyen, T.N. Nguyen, V.H. Dai, T.M. Dang, and S.K. Vo et al. Beijing genotype of Mycobacterium tuberculosis is significantly associated with high-level fluoroquinolone resistance in Vietnam Antimicrob Agents Chemother 53 2009 4835 4839
26. B. Varghese, A. Hillemann, D.R. Wijayanti, M. Shoukri, F. Al-rabiah, and R. Al-Omari et al. New insight into the molecular characterization of isoniazid and rifampicin resistant Mycobacterium tuberculosis strains from Saudi Arabia Infect Genet Evol 12 2012 549 556
27. I. Escribano, J.C. Rodríguez, B. Llorca, E. García-Pachon, M. Ruiz, and G. Royo Importance of the efflux pump systems in the resistance of Mycobacterium tuberculosis to fluoroquinolones and linezolid Chemotherapy 53 2007 397 401
28. L. Amaral, and M. Viveiros Why thioridazine in combination with antibiotics cures extensively drug-resistant Mycobacterium tuberculosis infections Int J Antimicrob Agents 39 2012 376 380
29. V. Jarlier, and H. Nikaido Mycobacterial cell wall: structure and role in natural resistance to antibiotics FEMS Microbiol Lett 123 1994 11 18
30. A.A. Velayati, P. Farnia, T.A. Ibrahim, R.Z. Haroun, H.O. Kuan, and J. Ghanavi et al. Differences in cell wall thickness between resistant and nonresistant strains of Mycobacterium tuberculosis: using transmission electron microscopy Chemotherapy 55 2009 303 307